GBA1 and Parkinson disease: Together with the search for GBA-associated biomarkers, which could potentially predict the phenoconversion from GBA asymptomatic carriers to an overt PD phenotype, the identification of molecular mechanisms contributing to early onset as well as a more severe phenotype in carriers of GBA mutations still represents an unmet need.